Shepherd Kaplan Krochuk LLC Cuts Holdings in Thermo Fisher Scientific Inc. (TMO)

Shepherd Kaplan Krochuk LLC lowered its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 12.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,731 shares of the medical research company’s stock after selling 841 shares during the period. Thermo Fisher Scientific comprises 0.9% of Shepherd Kaplan Krochuk LLC’s portfolio, making the stock its 21st largest holding. Shepherd Kaplan Krochuk LLC’s holdings in Thermo Fisher Scientific were worth $1,283,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Aries Wealth Management raised its position in shares of Thermo Fisher Scientific by 1.1% in the fourth quarter. Aries Wealth Management now owns 4,269 shares of the medical research company’s stock valued at $955,000 after buying an additional 45 shares during the last quarter. Balasa Dinverno & Foltz LLC grew its holdings in Thermo Fisher Scientific by 2.1% in the fourth quarter. Balasa Dinverno & Foltz LLC now owns 2,238 shares of the medical research company’s stock valued at $501,000 after purchasing an additional 46 shares during the period. Atlas Capital Advisors LLC grew its holdings in Thermo Fisher Scientific by 5.5% in the fourth quarter. Atlas Capital Advisors LLC now owns 923 shares of the medical research company’s stock valued at $207,000 after purchasing an additional 48 shares during the period. Johnson Financial Group Inc. grew its holdings in Thermo Fisher Scientific by 8.0% in the fourth quarter. Johnson Financial Group Inc. now owns 673 shares of the medical research company’s stock valued at $151,000 after purchasing an additional 50 shares during the period. Finally, BLB&B Advisors LLC grew its holdings in Thermo Fisher Scientific by 4.2% in the fourth quarter. BLB&B Advisors LLC now owns 1,252 shares of the medical research company’s stock valued at $280,000 after purchasing an additional 51 shares during the period. Institutional investors own 87.11% of the company’s stock.

A number of equities research analysts recently issued reports on the stock. Zacks Investment Research downgraded shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Friday, November 30th. Robert W. Baird boosted their target price on shares of Thermo Fisher Scientific from $264.00 to $270.00 and gave the company an “outperform” rating in a report on Wednesday, January 30th. Finally, BTIG Research boosted their target price on shares of Thermo Fisher Scientific to $290.00 and gave the company a “buy” rating in a report on Thursday, January 31st. Three equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $275.70.



TMO opened at $261.43 on Friday. The company has a quick ratio of 1.23, a current ratio of 1.73 and a debt-to-equity ratio of 0.64. Thermo Fisher Scientific Inc. has a 52-week low of $199.85 and a 52-week high of $266.18. The company has a market cap of $104.21 billion, a price-to-earnings ratio of 23.51, a price-to-earnings-growth ratio of 1.68 and a beta of 1.13.

Thermo Fisher Scientific (NYSE:TMO) last announced its earnings results on Wednesday, January 30th. The medical research company reported $3.25 earnings per share for the quarter, beating the consensus estimate of $3.19 by $0.06. The business had revenue of $6.51 billion during the quarter, compared to the consensus estimate of $6.26 billion. Thermo Fisher Scientific had a net margin of 12.06% and a return on equity of 16.86%. The business’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.79 earnings per share. On average, research analysts predict that Thermo Fisher Scientific Inc. will post 12.14 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 16th. Stockholders of record on Friday, March 15th will be paid a $0.19 dividend. The ex-dividend date is Thursday, March 14th. This is an increase from Thermo Fisher Scientific’s previous quarterly dividend of $0.17. This represents a $0.76 annualized dividend and a dividend yield of 0.29%. Thermo Fisher Scientific’s dividend payout ratio is 6.12%.

In related news, CFO Stephen Williamson sold 2,500 shares of the company’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $266.00, for a total value of $665,000.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CAO Peter E. Hornstra sold 5,920 shares of the company’s stock in a transaction on Friday, February 15th. The shares were sold at an average price of $250.00, for a total transaction of $1,480,000.00. Following the completion of the sale, the chief accounting officer now directly owns 17,057 shares in the company, valued at $4,264,250. The disclosure for this sale can be found here. Insiders sold 36,927 shares of company stock valued at $9,388,124 over the last 90 days. Insiders own 0.49% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Shepherd Kaplan Krochuk LLC Cuts Holdings in Thermo Fisher Scientific Inc. (TMO)” was first published by Dakota Financial News and is the property of of Dakota Financial News. If you are accessing this story on another site, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this story can be read at https://dakotafinancialnews.com/2019/03/15/shepherd-kaplan-krochuk-llc-cuts-holdings-in-thermo-fisher-scientific-inc-tmo.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Read More: Average Daily Trade Volume – ADTV

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.